Beyond the medicine cabinet: an analysis of where and why medications accumulate - PubMed
. 2008 Nov;34(8):1157-69.
doi: 10.1016/j.envint.2008.05.002. Epub 2008 Jun 20.
Affiliations
- PMID: 18571238
- DOI: 10.1016/j.envint.2008.05.002
Beyond the medicine cabinet: an analysis of where and why medications accumulate
Ilene Sue Ruhoy et al. Environ Int. 2008 Nov.
Abstract
Active pharmaceutical ingredients (APIs) from medications can enter the environment as trace contaminants, at individual concentrations generally below a part per billion (microg/L). APIs enter the environment primarily via the discharge of raw and treated sewage. Residues of unmetabolized APIs from parenteral and enteral drugs are excreted in feces and urine, and topically applied medications are washed from skin during bathing. These trace residues may pose risks for aquatic life and cause concern with regard to subsequent human exposure. APIs also enter the environment from the disposal of unwanted medications directly to sewers and trash. The relative significance of this route compared with excretion and bathing is poorly understood and has been subject to much speculation. Two major aspects of uncertainty exist: the percentage of any particular API in the environment originating from disposal is unknown, and disposal undoubtedly occurs from a variety of dispersed sources. Sources of disposal, along with the types and quantities of APIs resulting from each source, are important to understand so that effective pollution prevention approaches can be designed and implemented. Accumulation of leftover, unwanted drugs poses three major concerns: (i) APIs disposed to sewage or trash compose a diverse source of potential chemical stressors in the environment. (ii) Accumulated drugs represent increased potential for drug diversion, with its attendant risks of unintentional poisonings and abuse. (iii) Leftover drugs represent wasted healthcare resources and lost opportunities for medical treatment. This paper has four major purposes: (1) Define the processes, actions, and behaviors that control and drive the consumption, accumulation, and need for disposal of pharmaceuticals. (2) Provide an overview of the diverse locations where drugs are used and accumulate. (3) Present a summary of the first cataloging of APIs disposed by a defined subpopulation. (4) Identify opportunities for pollution prevention and source reduction.
Similar articles
-
Illicit drugs: contaminants in the environment and utility in forensic epidemiology.
Daughton CG. Daughton CG. Rev Environ Contam Toxicol. 2011;210:59-110. doi: 10.1007/978-1-4419-7615-4_3. Rev Environ Contam Toxicol. 2011. PMID: 21170703 Review.
-
Ruhoy IS, Daughton CG. Ruhoy IS, et al. Sci Total Environ. 2007 Dec 15;388(1-3):137-48. doi: 10.1016/j.scitotenv.2007.08.013. Epub 2007 Sep 20. Sci Total Environ. 2007. PMID: 17888494
-
Eco-directed sustainable prescribing: feasibility for reducing water contamination by drugs.
Daughton CG. Daughton CG. Sci Total Environ. 2014 Sep 15;493:392-404. doi: 10.1016/j.scitotenv.2014.06.013. Epub 2014 Jun 20. Sci Total Environ. 2014. PMID: 24956075
-
Daughton CG, Ruhoy IS. Daughton CG, et al. Environ Toxicol Chem. 2009 Dec;28(12):2495-521. doi: 10.1897/08-382.1. Epub 2009 Apr 21. Environ Toxicol Chem. 2009. PMID: 19382823 Review.
-
The afterlife of drugs and the role of pharmEcovigilance.
Daughton CG, Ruhoy IS. Daughton CG, et al. Drug Saf. 2008;31(12):1069-82. doi: 10.2165/0002018-200831120-00004. Drug Saf. 2008. PMID: 19026025
Cited by
-
Activated Carbon-Based System for the Disposal of Psychoactive Medications.
Song Y, Manian M, Fowler W, Korey A, Kumar Banga A. Song Y, et al. Pharmaceutics. 2016 Nov 7;8(4):31. doi: 10.3390/pharmaceutics8040031. Pharmaceutics. 2016. PMID: 27827989 Free PMC article.
-
Massoud MA, Chami G, Al-Hindi M, Alameddine I. Massoud MA, et al. Environ Manage. 2016 May;57(5):1125-37. doi: 10.1007/s00267-016-0666-6. Epub 2016 Feb 5. Environ Manage. 2016. PMID: 26847599
-
Alfian SD, Insani WN, Halimah E, Qonita NA, Jannah SS, Nuraliyah NM, Supadmi W, Gatera VA, Abdulah R. Alfian SD, et al. Front Pharmacol. 2021 Apr 26;12:630434. doi: 10.3389/fphar.2021.630434. eCollection 2021. Front Pharmacol. 2021. PMID: 33981221 Free PMC article.
-
Koyanagi K, Kubota T, Kobayashi D, Kihara T, Yoshida T, Miisho T, Miura T, Sakamoto Y, Takaki J, Seo T, Shimazoe T. Koyanagi K, et al. Front Pharmacol. 2016 Jul 20;7:212. doi: 10.3389/fphar.2016.00212. eCollection 2016. Front Pharmacol. 2016. PMID: 27489544 Free PMC article.
-
Lai PSM, Tan KM, Lee HG, Wong YY, Azhari Wasi NA, Sim SM. Lai PSM, et al. Malays Fam Physician. 2021 Feb 1;16(1):56-63. doi: 10.51866/oa1013. eCollection 2021 Mar 25. Malays Fam Physician. 2021. PMID: 33948143 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical